Endoscopic Therapy for Barrett's Esophagus

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 7, 2009, Pages 716-720

  Sampliner, Richard E ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; LIQUID NITROGEN; OMEPRAZOLE; PHOTOFRIN; PROTON PUMP INHIBITOR;

BARRETT ESOPHAGUS; CLINICAL TRIAL; CRYOTHERAPY; DRUG MEGADOSE; ELECTROCOAGULATION; ENDOSCOPIC ABLATION THERAPY; ENDOSCOPIC SURGERY; ENDOSCOPIC THERAPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS DISEASE; ESOPHAGUS DYSPLASIA; ESOPHAGUS SURGERY; HUMAN; INTERMETHOD COMPARISON; PHOTODYNAMIC THERAPY; RADIOFREQUENCY ABLATION; REVIEW; TREATMENT INDICATION;

ABLATION TECHNIQUES; BARRETT ESOPHAGUS; ENDOSCOPY; HUMANS;

EID: 67649382771     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2009.03.011     Document Type: Review

References (32)

1. Prasad G.A., Wang K.K., Buttar N.S., et al. Long term survival following endoscopic and surgical treatment of high grade dysplasia in Barrett's esophagus. Gastroenterology 132 (2007) 1226-1233
2. Shaheen N.J., Sharma P., Overholt R.F., et al. A randomized, multicenter, sham-controlled trial of radiofrequency ablation for subjects with Barrett's esophagus containing dysplasia. Gastroenterology 134 (2008) A-37
3. Buskens C.J., Westerterp M., Lagarde S.M., et al. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc 60 (2004) 703-710
4. Manner H., May A., Pech O., et al. Early Barrett's carcinoma with "low risk" submucosal invasion: long-term results of endoscopic resection with a curative intent. Am J Gastroenterol 103 (2008) 2589-2597
5. Peters F.P., Brakenhoff K.P.M., Curvers W.L., et al. Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett's esophagus. Gastrointest Endosc 67 (2008) 604-609
6. Ell C., May A., Pech O., et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc 65 (2007) 3-10
7. Ell C., May A., Gossner L., et al. Endoscopic mucosal resection of early cancer and high grade dysplasia in Barrett's esophagus. Gastroenterology 118 (2000) 670-677
8. Sampliner R.E., Fennerty M.B., and Garewal H.S. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointest Endosc 44 (1996) 532-535
9. Kovacs B., Chen Y., Lewis T., et al. Successful reversal of Barrett's esophagus with multipolar electrocoagulation despite inadequate acid suppression. Gastrointest Endosc 9 (1999) 547-553
10. Montes C.G., Brandalise N.A., Deliza R., et al. Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus. Gastrointest Endosc 50 (1999) 173-177
11. Sampliner R.E., Faigel D., Fennerty M.B., et al. Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointest Endosc 53 (2001) 554-558
12. Morina M., Rebecchi M., Giaccones C., et al. Endoscopic ablation of Barrett's esophagus using argon plasma coagulation (APC) following surgical laparoscopic fundoplication. Surg Endosc 17 (2003) 539-542
13. Tigges H., Fuchs K.H., Maroske J., et al. Combination of endoscopic argon plasma coagulation and antireflux surgery for treatment of Barrett's esophagus. J Gastrointest Surg 5 (2001) 251-259
14. Schulz H., Miehlke S., Antos D., et al. Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole. Gastrointest Endosc 51 (2000) 659-663
15. Madisch A., Miehlke S., Bayerdorffer E., et al. Long-term follow-up after complete ablation of Barrett's esophagus with argon plasma coagulation. World J Gastroenterol 11 (2005) 1182-1186
16. VanLaethem J.L., Jagodzinski R., Peny M.O., et al. Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma. Endoscopy 33 (2001) 257-261
17. Attwood S.E.A., Lewis C.J., Caplin S., et al. Argon plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol 1 (2003) 258-263
18. Wakelin D.E., Al-Mutawa T.S., Wendel C.S., et al. A predictive model for length of Barrett's esophagus with hiatal hernia length and duration of esophageal acid exposure. Gastrointest Endosc 58 (2003) 350-355
19. Fleischer D.E., Overholt R.F., Sharma V.K., et al. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5 year follow-up. Gastrointest Endosc 68 (2008) 867-876
20. Ganz R.A., Overholt R.F., Sharma V.K., et al. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. multicenter study. Gastrointest Endosc 68 (2008) 35-40
21. Overholt B., Lightdale C., Wang K., et al. Photodynamic therapy (PDT) with porfimer sodium for the ablation of high-grade dysplasia in Barrett's esophagus (BE): international, partially blinded randomized phase III trial. Gastrointest Endosc 62 (2005) 488-498
22. Overholt B.F., Wang K.K., Burdick J.S., et al. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastroenterologist 66 (2007) 460-468
23. Gossner L., Stolte M., Sroka R., et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology 114 (1998) 448-455
24. Pech O., Gossner L., May A., et al. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. Gastrintest Endosc 62 (2005) 24-30
25. Mackenzie G.D., Jamieson N.F., Novelli M.R., et al. How light dosimetry influences the efficacy of photodynamic therapy with 5-aminolevulinic acid for ablation of high-grade dysplasia in Barrett's esophagus. Lasers Med Sci 23 (2007) 203-210
26. Ackroyd R., Brown N.J., Davis M.F., et al. Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial. Gut 47 (2000) 612-617
27. Johnston M.H., Horwhat J.D., Dubois A., et al. Endoscopic cryotherapy in the swine esophagus: a follow up study. Gastrointest Endosc 49 (1999) AB126
28. Pasricha P.J., Hill S., Wadwa K.S., et al. Endoscopic cryotherapy: experimental results and first clinical use. Gastrointest Endosc 49 (1999) 627-631
29. Garewal H.S., Ramsey L., Sharma P., et al. Biomarker studies in reversed Barrett's esophagus. Am J Gastroenterol 94 (1999) 2829-2833
30. Krishnadath K.K., Wang K.K., Taniguchi K., et al. Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology 119 (2000) 624-630
31. Bronner M.P., Overholt R.F., Taylor S.L., et al. Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia. Gastroenterology 136 (2009) 56-64
32. Pech O., Behrens A., May A., et al. Long term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 57 (2008) 1200-1206